Pfizer Inc.
SOLID DOSAGE FORMS OF PALBOCICLIB

Last updated:

Abstract:

The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.

Status:
Application
Type:

Utility

Filling date:

17 Jun 2021

Issue date:

14 Oct 2021